<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen W</submitter><funding>Cancer Research UK</funding><funding>Deutsche Forschungsgemeinschaft (German Research Foundation)</funding><funding>National Institute for Health Research (NIHR)</funding><funding>China Scholarship Council (CSC)</funding><pagination>165</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11697447</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>Fast and reliable identification of bacteria directly in clinical samples is a critical factor in clinical microbiological diagnostics. Current approaches require time-consuming bacterial isolation and enrichment procedures, delaying stratified treatment. Here, we describe a biomarker-based strategy that utilises bacterial small molecular metabolites and lipids for direct detection of bacteria in complex samples using mass spectrometry (MS). A spectral metabolic library of 233 bacterial species is mined for markers showing specificity at different phylogenetic levels. Using a univariate statistical analysis method, we determine 359 so-called taxon-specific markers (TSMs). We apply these TSMs to the in situ detection of bacteria using healthy and cancerous gastrointestinal tissues as well a</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Universal, untargeted detection of bacteria in tissues using metabolomics workflows.</pubmed_title><pmcid>PMC11697447</pmcid><funding_grant_id>P64610</funding_grant_id><funding_grant_id>505372148</funding_grant_id><funding_grant_id>ICL BRC Molecular Phenomics</funding_grant_id><funding_grant_id>202208320033</funding_grant_id><funding_grant_id>C52720/A25038</funding_grant_id><funding_grant_id>CRC1182</funding_grant_id><pubmed_authors>Ramonaite T</pubmed_authors><pubmed_authors>Janßen KP</pubmed_authors><pubmed_authors>Kinross J</pubmed_authors><pubmed_authors>Qiu M</pubmed_authors><pubmed_authors>Liebeke M</pubmed_authors><pubmed_authors>Goldin RD</pubmed_authors><pubmed_authors>Rebec M</pubmed_authors><pubmed_authors>Zborovsky L</pubmed_authors><pubmed_authors>McKenzie JS</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Paizs P</pubmed_authors><pubmed_authors>Strittmatter N</pubmed_authors><pubmed_authors>Sadowski M</pubmed_authors><pubmed_authors>Mejias-Luque R</pubmed_authors><pubmed_authors>Takats Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Universal, untargeted detection of bacteria in tissues using metabolomics workflows.</name><description>Fast and reliable identification of bacteria directly in clinical samples is a critical factor in clinical microbiological diagnostics. Current approaches require time-consuming bacterial isolation and enrichment procedures, delaying stratified treatment. Here, we describe a biomarker-based strategy that utilises bacterial small molecular metabolites and lipids for direct detection of bacteria in complex samples using mass spectrometry (MS). A spectral metabolic library of 233 bacterial species is mined for markers showing specificity at different phylogenetic levels. Using a univariate statistical analysis method, we determine 359 so-called taxon-specific markers (TSMs). We apply these TSMs to the in situ detection of bacteria using healthy and cancerous gastrointestinal tissues as well a</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-04T12:02:22.918Z</modification><creation>2025-04-04T12:02:22.918Z</creation></dates><accession>S-EPMC11697447</accession><cross_references><pubmed>39747039</pubmed><doi>10.1038/s41467-024-55457-7</doi></cross_references></HashMap>